B7-H3 (CD276) overexpression has been found in a variety of human cancers, including lung adenocarcinoma, craniopharyngioma, neuroblastoma, medulloblastoma, glioma, ovarian cancer, pancreatic cancer, and acute myeloid leukemia. Here, CD276 is linked to glioma.